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Abstract 
Background: The genomes of HIV-2 and some SIV strains contain the accessory gene vpx, which carries out several 
functions during infection, including the downregulation of SAMHD1. Vpx is also commonly used in experiments to 
increase HIV-1 infection efficiency in myeloid cells, particularly in studies that investigate the activation of antiviral 
pathways. However, the potential effects of Vpx on cellular innate immune signaling is not completely understood. 
We investigated whether and how Vpx affects ISG responses in monocytic cell lines and MDMs during HIV-1 infection.
Results: HIV-1 infection at excessively high virus doses can induce ISG activation, although at the expense of high 
levels of cell death. At equal infection levels, the ISG response is potentiated by the presence of Vpx and requires 
the initiation of reverse transcription. The interaction of Vpx with the DCAF1 adaptor protein is important for the 
enhanced response, implicating Vpx-mediated degradation of a host factor. Cells lacking SAMHD1 show similarly aug-
mented responses, suggesting an effect that is independent of SAMHD1 degradation. Overcoming SAMHD1 restric-
tion in MDMs to reach equal infection levels with viruses containing and lacking Vpx reveals a novel function of Vpx in 
elevating innate immune responses.
Conclusions: Vpx likely has as yet undefined roles in infected cells. Our results demonstrate that Vpx enhances ISG 
responses in myeloid cell lines and primary cells independently of its ability to degrade SAMHD1. These findings have 
implications for innate immunity studies in myeloid cells that use Vpx delivery with HIV-1 infection.
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Background
Organisms are equipped with protective mechanisms 
against pathogenic invasions, for which interferons 
(IFNs) are critical regulators. For many viral pathogens, 
a functional innate immune system is essential for com-
batting infection both in the initial stages following virus 
encounter and for mounting highly specific adaptive 
immune responses at later stages of infection. At the 
cellular level, the coexistence of viruses with their hosts 
for millions of years have resulted in the evolution of 
multiple, robust, and sometimes overlapping cellular 
pathways that detect and respond to viral infections. It 
is therefore not surprising that many viruses, including 
human and simian immunodeficiency viruses (HIV and 
SIV), have also evolved strategies that specifically coun-
teract these pathways and modify host responses.
The principal target of HIV-1  is CD4+ T-cells; how-
ever, dendritic cells, macrophages and natural killer cells 
are also activated during acute infection (reviewed in [1, 
2]). IFNs and other proinflammatory cytokines produced 
during the acute phase help recruit additional target cells 
to the sites of replication and facilitate viral spread. In 
the later stages of infection macrophage-tropic viral iso-
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replicate efficiently in the central nervous system and are 
often implicated in HIV-associated neurocognitive disor-
ders. Thus, many different cell types are involved in the 
response to HIV-1 infection and it is important to under-
stand how HIV-1 interacts with the innate immune sys-
tem in these cells.
Complex retroviruses such as HIV and SIVs harbor 
multiple accessory genes that carry out various functions 
in infected cells, from counteracting specific restric-
tion and resistance factors to cell cycle regulation, from 
transcriptional modulation of viral and host genes to 
alterations in cellular trafficking pathways, among oth-
ers (reviewed in [4–6]). Vpx is an accessory gene that 
is absent in HIV-1, but present in several SIV strains as 
well as HIV-2, which allows efficient infection of mye-
loid cells and resting CD4+ T-cells [7–9]. Vpx interacts 
with the DCAF1 adaptor to associate with the CUL4-
DDB1 ubiquitin ligase complex and target select host 
proteins for proteasomal degradation (reviewed in [6, 
10]). The most prominently studied host targets of Vpx 
thus far are SAMHD1, which depletes cellular dNTP 
pools thereby preventing reverse transcription [11], and 
TASOR (FAM208A), which silences both unintegrated 
[12] and integrated, latent retroviral DNA [13, 14] as 
part of the HuSH complex [15]. As HIV-1 strains do not 
contain Vpx, the necessity of counteracting these factors 
has been brought into question (reviewed in [5]). How-
ever, SAMHD1 antagonism by Vpr is maintained during 
natural SIV infection in African green monkeys [16], sug-
gesting a significant evolutionary pressure on viral fitness 
exerted by this host factor in vivo.
Many studies investigating innate immune responses 
against retroviruses utilize Vpx delivery to achieve high 
enough infection levels in myeloid cells [17–22], although 
some notable exceptions do exist [23–25]. Similarly, 
for gene silencing experiments, Vpx is typically deliv-
ered alongside the shRNA in VLPs to enhance knock-
down efficiency. Whether Vpx has other functions in 
the cell or how it modulates host signaling pathways is 
not fully understood. Here we report that HIV-1  infec-
tion of monocytic cells with high levels of virus input 
can result in IFN production and ISG activation, albeit 
at the expense of inducing cell death. Vpx potentiates 
ISG responses during HIV-1  infection independently of 
SAMHD1 degradation, but requires the interaction with 
the ubiquitin-proteasome system, implicating another 
host factor targeted for degradation by Vpx. The ability of 
Vpx to increase HIV-1 infection efficiency in MDMs can 
be dissociated from its ability to augment ISG responses 
by overcoming SAMHD1 restriction in these cells. 
Under the circumstances where comparable infection 
is achieved by viruses with and without Vpx, those that 
contain Vpx still yield elevated responses. These results 
demonstrate a novel, SAMHD1-independent function of 
Vpx in promoting ISG expression during HIV infection, 
and have direct implications for studies investigating 
innate immune responses against retroviruses in myeloid 
cells.
Results
Vpx elevates ISRE responses in PMA‑differentiated THP‑1 
cells during HIV‑1 infection
To investigate the effect of Vpx on ISG responses 
caused by HIV-1  infection, THP-1 Lucia ISG reporter 
cells (hereafter “THP-1”) were used. These cells express 
secreted luciferase (lucia) under the control of an ISRE 
(IFN-stimulated response element) promoter, which 
serves as a convenient substitute for assessing ISG induc-
tion. PMA-differentiated cells were infected with increas-
ing concentrations of VSV-G pseudotyped, NL4.3-based, 
single-round, GFP-expressing reporter virus (hereaf-
ter HIV-1GFP) with or without the addition of a con-
stant level of VLPs containing  SIVmac239 Vpx  (VLPVpx). 
To enhance the packaging of Vpx, we used a modified 
construct where 10 amino acids in the p6 region has 
been replaced with the  SIVmac239 version, as previously 
described [26]. A dose-dependent increase in infection 
levels was observed, and infection in the presence of 
 VLPVpx was higher than in its absence as expected, due 
to the restrictive activity of SAMHD1 following PMA-
differentiation (Fig. 1a). ISRE-driven reporter expression 
was also dose-dependent, and  VLPVpx addition caused 
up to eight-fold higher reporter induction by HIV-1GFP 
(Fig. 1b). For easier comparison of the different infection 
levels with ISRE induction, each infection value (%GFP) 
was plotted against its own reporter activation (RLU) 
level, which showed consistently higher ISRE levels in the 
presence of  VLPVpx (Fig.  1c).  VLPVpx addition alone (in 
the absence of virus) did not result in increased reporter 
activity, and inhibition of reverse transcription by nevi-
rapine treatment blocked ISRE responses (Fig. 1d). Titra-
tion of IFN-β on reporter cells revealed a dose-dependent 
response in reporter activity (Fig. 1e). SAMHD1 degrada-
tion in cells receiving Vpx was observed, supporting the 
functionality of the packaged Vpx (Fig. 1f ).
Separate VLP delivery means a higher amount of viral 
capsid entering the cells, which has been proposed to 
stimulate innate immune signaling [18]. To control 
for this possibility, we conducted the same experi-
ments with a similar virus expressing firefly luciferase 
(HIV-1Luc) either alone or with Vpx packaged directly 
into the virions (HIV-1Luc + Vpx). In line with previous 
results, infection of PMA-differentiated THP-1 cells 
was dose dependent and more efficient in the presence 
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of virion-packaged Vpx, although this difference could 
be mostly overcome at higher concentrations (Fig. 1g). 
At equal virus doses, ISRE reporter induction reached 
5–14-fold higher levels in the presence of Vpx than in 
its absence (Fig. 1h). Plotting infection (Firefly) against 
ISRE induction (Lucia) revealed higher reporter acti-
vation at comparable infection levels (Fig.  1i). These 
results indicate that Vpx causes enhanced ISRE 
Fig. 1 THP-1 Lucia ISG cells were differentiated overnight with PMA (25 ng/ml) and infected with serial dilutions of VSV-G pseudotyped 
single-round HIV-1 reporter virus in the presence of  SIVmac Vpx, delivered either separately as VLPs (a–d) or packaged into the virions (g‑i). Infection 
levels were measured by flow cytometry (HIV-1GFP) or firefly luciferase assay (HIV-1Luc), and ISRE-driven reporter induction was quantified by lucia 
luciferase assay from culture supernatants 3 days post-infection. a Infection was measured by flow cytometry. b ISRE reporter induction was 
quantified by lucia luciferase expression. c Comparison of infection vs. ISRE induction. d Cells were transduced with  VLPVpx alone or with HIV-1GFP 
in the presence or absence of NVP; ISRE driven luciferase activity was quantified. e IFN-β was titrated on PMA-differentiated THP-1 Lucia ISG 
cells; reporter activity was measured after 3 days. f Western blot of total cell lysates after transduction with or without of Vpx showing SAMHD1 
levels (left), and levels of p24 and Vpx-myc in virions (right). g Infection was quantified by firefly luciferase at 3 dpi. h ISRE reporter induction was 
quantified by lucia luciferase expression. i Comparison of infection levels vs. reporter induction. VLP: virus-like particle; ISRE: IFN-stimulated response 
element; NVP: nevirapine. Data are from three replicates; error bars depict standard deviation
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activation during HIV-1  infection in PMA-differenti-
ated THP-1 cells, even when taking into consideration 
the difference in infection levels.
Vpx augments innate immune activation 
in undifferentiated THP‑1 cells during infection
To overcome the difference in infection levels between 
viruses with or without Vpx, from here on we used undif-
ferentiated THP-1 cells, where SAMHD1 is inactive due 
to the phosphorylation of a key residue [27]. Challeng-
ing undifferentiated cells with equal doses of HIV-1Luc 
with or without virion-packaged Vpx led to equal infec-
tion levels as expected (Fig. 2a), whereas ISRE induction 
was still potentiated in Vpx-containing virions, on aver-
age 4.3-fold (Fig. 2b). Plotting infection against reporter 
induction supported these findings (Fig.  2c). Titration 
of IFN-β on undifferentiated reporter cells also resulted 
in dose-dependent reporter activation, as expected 
(Fig.  2d). Degradation of SAMHD1 was observed in 
infected cells (Fig.  2e). The loss of SAMHD1 phospho-
rylation in THP-1 Lucia cells following PMA differentia-
tion after 1 and 4 days was also confirmed (Fig. 2f ). These 
results indicate that at the same level of HIV-1 infection, 
the presence of Vpx causes enhanced ISG responses in 
undifferentiated cells where SAMHD1 is inactive.
Virus input necessary for stimulating innate immunity 
causes high levels of cell death
We and others previously reported that HIV-1 does 
not strongly induce innate immune responses, unless 
the virus is supplemented with accessory genes from 
other lentiviruses, carries structural or enzymatic 
mutations, or is treated with chemicals that alter 
its uncoating kinetics or interfere with its engage-
ment with host factors [23, 24, 28–30]. We present 
here that ISG induction can occur when cells are 
challenged with excessively high virus concentra-
tions (Fig.  3a). Based on the estimation that one viral 
Fig. 2 THP-1 Lucia ISG cells (undifferentiated) were infected with serial dilutions of VSV-G pseudotyped HIV-1Luc reporter viruses with or without 
packaged  SIVmac Vpx. a Infection was quantified by firefly luciferase expression 2 days later. b ISRE reporter was quantified by lucia luciferase 
expression. c Comparison of infection vs. ISRE levels. d IFN-β was titrated on undifferentiated THP-1 reporter cells and luciferase activity in culture 
supernatants was measured. e Total cell lysates were analyzed by Western blot and probed with the indicated antibodies. f Representative Western 
blot of undifferentiated and PMA-differentiated cells (days 1 and 4 after PMA-treatment), showing phospho-T592 and total SAMHD1 levels. Data are 
from three replicates; error bars depict standard deviation
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core contains ~ 1500 CA monomers, p24 quantifica-
tion of viruses revealed that the two highest input 
doses correspond to 1.3 × 1010 to 4 × 1010 viral par-
ticles [31–33]. Importantly, at the highest dose pre-
sented here (8 × 106 pg RT units), flow cytometry 
profiles of infected cells revealed a drastic shift in the 
size and complexity (FSC vs. SSC) compared to unin-
fected cells, suggesting a substantial level of cell death 
(Fig.  3b). We repeated the infection with the same 
virus input level, this time with heat inactivated virus 
Fig. 3 a THP-1 Lucia ISG cells (undifferentiated) were infected with serial dilutions of VSV-G pseudotyped HIV-1GFP reporter viruses; nevirapine 
(NVP; 10 µM) was added as a control. ISRE reporter was quantified by lucia luciferase expression 2 days later. b Cells infected at the highest dose 
were analyzed by flow cytometry showing the shift in FSC/SSC profiles. c Live/dead staining vs. GFP expression confirmed cell death. d–f cells were 
challenged with HIV-1GFP in the presence or absence of NVP (10 µM) or with heat inactivated virus. Infection efficiency (d) and cell death (e) were 
evaluated by flow cytometry, ISRE reporter activity was quantified by luciferase assay of culture supernatants (f)
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or in the presence of 10 µM NVP. Live/dead staining 
confirmed that this shift was caused by extensive death 
(45–60%) in cells challenged with virus, compared to 
the basal rate of cell death (3–5%) in uninfected cells 
(Fig.  3c). GFP+ and dead cells formed two separate 
populations, suggesting that it is not the productively 
infected cells that are dying, although it remains pos-
sible that the GFP signal would be lost upon death. 
The pathway of cell death and the details of how it 
occurs are beyond the scope of this study. However, it 
should be mentioned that heat inactivation or RT inhi-
bition prevented infection, cell death, and ISG activa-
tion (Fig.  3d–f ), indicating that death was not caused 
by impurities in the viral supernatants and required 
at least the initiation of reverse transcription. Nota-
bly, the ISRE induction was not dissociable from cell 
death, as treatments that blocked ISRE induction also 
reversed the death phenotype. These results indicate 
that bombarding the cells with excessive amounts of 
virus can result in innate immune induction, however 
it comes at the cost of inducing massive amounts of 
cell death in this cell type.
The activity of Vpx in enhancing ISG responses occurs 
in the absence of SAMHD1
To investigate whether the ability of Vpx to enhance 
innate immune activation during HIV-1  infection was 
linked to SAMHD1, we assayed infection and ISG 
induction in SAMHD1 KO cells (Fig.  4a). The basal 
mRNA expression of innate immunity-related genes 
was higher in SAMHD1 KO cells compared to WT con-
trols, and ranged from 2–8-fold for IFNB1, IFIT1, IFIT2, 
ISG15,  CXCL10 and 60–70-fold for MX1 and IFI27 
(Fig. 4b). Challenging cells with the same amount of HIV-
1GFP yielded the same level of infection (74–78%) regard-
less of  VLPVpx addition (Fig. 4c). To compare the relative 
amount of type I IFN production, supernatants were 
collected from infected cells and assayed on HEK-Blue 
Fig. 4 SAMHD1 KO THP-1 cells (undifferentiated) were infected with HIV-1GFP in the presence or absence of VLPs containing Vpx. a Lysates from 
WT and KO cells were analyzed for SAMHD1 by Western blot. b Differences in basal mRNA levels between WT and KO cells for a panel of ISGs. 
c Infection levels were analyzed by flow cytometry. d Supernatants from infected cells were incubated with HEK-Blue IFN-α/β cells (HEK-Blue); SEAP 
assay was performed the next day to assess the presence of type I IFN in culture supernatants of infected cells. e RNA was isolated from infected 
cells and qRT-PCR was performed to quantify the mRNA levels of IFNB1, IFIT1 and IFIT2 (relative to HPRT1), and normalized to uninfected cells. 
f SAMHD1 KO THP-1 cells (undifferentiated) were infected HIV-1GFP with or without virion packaged Vpx, in the presence and absence of 10 µM NVP. 
Supernatants were analyzed for IFN-β secretion by ELISA. *p < 0.05, **p < 0.01, ***p < 0.001, ns: not significant
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IFN-α/β reporter cells (hereafter HEK-Blue), which 
allows the detection of bioactive type I IFN by secreted 
alkaline phosphatase (SEAP) that can be quantified by a 
colorimetric assay. Supernatants from SAMHD1 KO cells 
that were uninfected or infected only with  VLPVpx did not 
yield any reporter activity over the baseline, indicating a 
lack of type I IFN production (Fig. 4d). HIV-1GFP infec-
tion resulted in marked induction of SEAP activity, which 
was significantly higher in the presence of  VLPVpx than 
in its absence, despite similar infection levels (Fig.  4d). 
The mRNA levels for IFNB1, IFIT1 and IFIT2 followed 
the same pattern as type I IFN production (Fig.  4e). To 
quantify directly the amount of type I IFN produced, 
SAMHD1 KO cells were infected with HIV-1GFP with or 
without virion packaged Vpx, in the presence or absence 
of NVP, and IFN-β was quantified from culture superna-
tants 3 days later. Low but detectable level of IFN-β was 
produced in response to infection with HIV-1GFP, which 
was potentiated in the presence of Vpx (Fig. 4f ). In both 
cases, NVP treatment reversed the IFN-β production. 
Taken together, these results demonstrate that addition 
of Vpx during HIV-1  infection increases type I IFN and 
ISRE induction even in the absence of SAMHD1.
Vpx enhances innate immune responses to HIV‑1 
by targeting a host factor for degradation
Vpx can target a number of host proteins for degrada-
tion through its interaction with DCAF1 in infected cells. 
However, it was shown that Vpx can also affect certain 
host processes independently of its ability to degrade 
host proteins, for instance  via STING-mediated activa-
tion of the NF-κB pathway [34]. To investigate whether 
the enhanced immune responses by Vpx is caused by its 
ability to target proteins for degradation, VLPs contain-
ing Q76A mutant of Vpx were generated, which is defec-
tive in DCAF1 binding. Undifferentiated THP-1 reporter 
cells were infected with HIV-1GFP in the presence or 
absence VLPs that were either empty, or containing WT 
or Q76A Vpx. Infection levels were similar (~ 50%) in all 
cases, irrespective of the VLP presence or their contents 
(Fig.  5a). ISRE reporter activity was significantly higher 
in the presence of WT Vpx, whereas Q76A mutation 
abolished this response (Fig.  5b). WT Vpx, but not the 
Q76A mutant, efficiently degraded SAMHD1 in infected 
cells (Fig. 5c). Thus, the ability of Vpx to interact with the 
ubiquitin-proteasome system to target proteins for deg-
radation is required for this phenotype.
The enhancement of ISRE response is conserved in HIV‑2 
Vpx
We next asked whether HIV-2, which contains a vpx 
gene, mirrors the phenotype seen with  SIVmac Vpx. 
We infected THP-1 reporter cells with a single-round, 
VSV-G pseudotyped HIV-2GFP that either carried vpx 
or not. Using viruses with similar levels of p26 capsid 
(Fig.  5d), we observed similar infection levels in undif-
ferentiated cells, as expected (Fig.  5e), but higher ISRE 
reporter activation in the presence of HIV-2 Vpx (Fig. 5f ). 
These results suggest that the increased innate immune 
activation phenotype of  SIVmac Vpx is also conserved in 
HIV-2 Vpx.
A combined approach to overcome SAMHD1 restriction 
exposes an innate immune enhancement activity of Vpx
To test whether the increased innate immune responses 
during HIV-1  infection by Vpx also occurs in primary 
cells, we infected monocyte-derived macrophages 
(MDMs) with HIV-1GFP with or without packaged 
Vpx. Macrophages are largely refractory to infection 
by HIV-1  in the absence of Vpx due to the activity of 
SAMHD1. At equal input of Vpx−  and Vpx+ viruses, a 
pronounced difference in infection was observed, con-
comitant with SAMHD1 degradation (Additional file  1: 
Fig. S1A, B). In accordance with the high infection level 
in the presence of Vpx, there was also a marked increase 
in the mRNA expression profiles for a panel of ISGs 
(Additional file 1: Fig. S1C). In an effort to overcome the 
infectivity difference between viruses containing and 
lacking Vpx, we used different input doses of HIV-1Luc 
to reach the same level of infection, which was achieved 
when 500 times more Vpx− virus was used compared to 
the Vpx+ virus (data not shown). However, due to vol-
ume limitations, it was not possible to simply add 500-
fold more virus, but rather the Vpx+ virus input had 
to be decreased in order to get equal infection levels. 
Reducing the amount of virus input, in turn, reversed any 
ISG induction that could previously only be observed at 
the highest doses of virus (Fig. 3a, and data not shown). 
These results revealed the challenges of dissociating the 
infectivity boost conferred to HIV-1 by Vpx from its 
enhancement of innate immune responses during MDM 
infection, and emphasized the necessity of overcoming 
SAMHD1 restriction in other ways.
 To equalize infection levels in MDMs between 
viruses containing and lacking Vpx, it was neces-
sary to overcome SAMHD1 restriction through other 
means. Knockdown of SAMHD1 using siRNA showed 
only limited success, and addition of dNTPs partially, 
but not fully, overcame SAMHD1 restriction (data not 
shown). Using an excess of HIV-1GFP (10–100-fold) 
simultaneously with dNTP addition resulted in com-
parable infection levels with its Vpx+ counterpart, 
allowing direct assessment of the effects the presence 
of Vpx might have on ISG induction (Fig. 6a). In case of 
HIV-1GFP with excess virus input and 2.5 mM dNTPs, 
GFP + cells ranged from 23–57%, whereas in the case of 
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HIV-1GFP + Vpx (no dNTP) infection level was between 
25–37% (Fig.  6a). Supernatants from infected cells 
were analyzed for type I IFN production on HEK-Blue 
reporter cells, where Vpx + viruses yielded a higher 
activity than Vpx- viruses (Fig.  6b). For all virus con-
centrations tested, the mRNA expression for IFNB1, 
IFIT1 and IFIT2 were upregulated to a higher degree in 
the presence of Vpx than in its absence, despite com-
parable infection levels (Fig.   6c; 1× vs. 10×) and in 
some cases even though Vpx-containing virus resulted 
in less GFP + cells (Fig. 6c; 3× vs. 100×). The difference 
between mRNA expression profiles induced by HIV-
1GFP and HIV-1GFP + Vpx ranged from 6–47-fold vs. 
73–111-fold for IFNB1, 16–180-fold vs. 200–300-fold 
for IFIT1, and 6–63-fold vs. 89–98-fold for IFIT2, 
respectively, in agreement with the HEK-Blue profiles. 
To ensure that the observed IFN response was due to 
successful infection, we repeated the MDM infection 
with HIV-1GFP supplemented by dNTPs in the presence 
and absence of NVP. Infection resulted in increased 
mRNA expression of our ISG panel (Fig. 6d), as well as 
increased secretion of IFN-β (Fig.  6e), both of which 
were sensitive to RT inhibition. As mentioned above, it 
is rather complicated to reach exactly the same infec-
tion level in MDMs with viruses that differ in their 
Vpx content. Challenge with excess virus translates 
to an excess number of viral cores entering the cells, 
as viruses are VSV-G pseudotyped and no additional 
Fig. 5 a–c THP-1 Lucia ISG cells (undifferentiated) were infected with HIV-1GFP in the presence or absence of VLPs containing WT or Q76A 
Vpx. a Infected cells were analyzed by flow cytometry 2 days post-infection. b ISRE reporter induction was assessed by lucia luciferase assay of 
supernatants from infected cells. c Cell lysates were collected from infected cells and analyzed on a Western blot, probing for SAMHD1. d–f THP-1 
Lucia ISG cells (undifferentiated) were infected with a single-round HIV-2GFP with or without its own Vpx. d Virions were run on a Western blot and 
probed for p26 CA using a p24 antibody known to cross react with HIV-2 CA [47]. Infection was quantified by flow cytometry (e) and ISRE induction 
was measured by luciferase activity (f). *p < 0.05, **p < 0.01
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block is expected at the entry level. Despite the higher 
number of capsids entering the cells and ultimately 
achieving similar infection levels in MDMs, viruses 
containing Vpx still resulted in markedly increased ISG 
responses.
Vpx mildly increases IFN‑β and ISRE‑driven transcriptional 
activity
To investigate whether Vpx enhances transcription from 
a type I IFN inducible promoter, we transfected HEK-
Blue cells with Vpx or a control plasmid and assayed 
Fig. 6 a, b MDMs were infected with different amounts of HIV-1GFP with or without virion-packaged Vpx in the presence or absence of extracellular 
dNTP addition to match infection levels. a Infection was assessed by flow cytometry. b Supernatants from infected cells were assayed on HEK-Blue 
IFN-α/β cells for the presence of type I IFN. c mRNA levels for IFNB1, IFIT1 and IFIT2 were quantified by qRT-PCR and normalized to uninfected cells. d 
MDMs were infected with HIV-1GFP with dNTP addition, in the presence or absence of 10 µM NVP. mRNA levels for the indicated ISGs were measured 
by RT-qPCR, normalized to HPRT1 and then to uninfected cells. e Supernatants from the infected MDMs in d were assessed for IFN-β secretion by 
ELISA. N.D.: Not detected.
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for SEAP reporter in culture supernatants. Treatment 
of reporter cells with IFN-β, but not IFN-γ, resulted in 
strong induction of SEAP activity compared to untreated 
controls; however, this activation was not altered by the 
presence of Vpx (Additional file  2: Fig. S2A). The cells 
responded to type I IFN treatment in a dose-dependent 
manner, while VLP delivery, whether empty or Vpx-
containing, did not affect the reporter levels triggered 
by the different IFN doses (Additional file  2: Fig. S2B). 
To test whether Vpx alters innate immune responses in 
the context of a different virus that strongly activates 
IFN response, THP-1 cells were infected with Sendai 
Virus (SeV) either alone, or in combination with VLPs 
with or without Vpx. SeV infection resulted in strong 
ISRE reporter expression, but  VLPVpx addition did not 
alter the reporter activity (Additional file  2: Fig. S2C). 
In each case, it is possible that IFN-β treatment or SeV 
infection promoted such high levels of induction that 
the system was saturated towards any additional effects 
by Vpx. To control for this possibility, we co-transfected 
293T cells with transcriptional reporter constructs for 
IFN-β and ISRE-driven luciferase plasmids, along with 
Vpx or a control GFP-expressing plasmid. Reporter acti-
vation revealed a mild (3–4 fold) average stimulation of 
basal levels in the presence of Vpx compared to control 
plasmid for both IFN-β and ISRE promoters (Additional 
file  2: Fig. S2D). To overcome potential transfection-
dependent artifacts, we repeated the reporter assays in 
293T cells transduced with empty or Vpx-containing 
VLPs, the latter resulting in higher reporter activity from 
both promoters (Additional file 2: Fig. S2E). Overall these 
results suggest that Vpx can cause transcriptional activa-
tion of promoters relevant to innate immune signaling 
pathways, albeit at relatively mild levels, which may help 
explain the enhanced innate immune responses observed 
during HIV-1 infection in the presence of Vpx.
Discussion
We show here that the presence of Vpx during 
HIV-1  infection, whether packaged into the virions or 
delivered separately as VLPs, potentiates innate immune 
responses in differentiated and undifferentiated THP-1 
cells, as well as MDMs. This effect cannot be accounted 
for by SAMHD1 targeting, as SAMHD1 KO cells also 
show elevated responses in the presence of Vpx. Notably, 
a detectable ISG response is only feasible using exces-
sive amounts of virus, at least in THP-1 cells, which ends 
up causing high levels of cell death independently of the 
presence or absence of Vpx. The DCAF1 interaction-defi-
cient Vpx mutant fails to augment ISG expression, thus 
the mechanism likely involves targeting a host protein by 
Vpx for proteasomal degradation. Overcoming the dif-
ference in infection levels in MDMs via dNTP addition 
and using a high ratio of Vpx−/Vpx+ viruses, we uncover 
an innate immune enhancement phenotype of Vpx that 
occurs even in the absence of SAMHD1.
Several studies have implicated Vpx in the negative 
regulation of innate immune signaling pathways, specifi-
cally the NF-κB pathway. In one study, Vpx was shown to 
inhibit STING-induced NF-κB responses without alter-
ing STING-induced IRF3 responses [34]. Although the 
mechanism is not known, inhibition of NF-κB responses 
by Vpx required direct interaction with STING, but was 
independent of the ability of Vpx to target host proteins 
for degradation, as the Q76A mutant was still functional. 
In a second study, Vpx was shown to inhibit NF-kB sign-
aling in response to all stimuli, by directly interacting 
with the p65 subunit, although not involving proteaso-
mal degradation [35]. These reports describe an activity 
of Vpx that is different than the one described in our 
study, in which the Q76A mutant no longer stimulates 
ISG responses. Thus, the ability of Vpx to increase ISG 
responses most likely involves a mechanism involving 
ubiquitin-mediated protein degradation, although it is 
not possible to rule out additional effects that this muta-
tion might have on Vpx function. HIV-1  infection was 
previously reported to stimulate type I IFN production 
through the IRF pathway [20, 36, 37], which we show is 
potentiated by Vpx, thus it remains possible that NF-κB 
responses are impaired in the presence of infection with 
Vpx, whereas the IRF3/IRF7 signaling remains active.
SAMHD1 was shown to be critical for the replica-
tion stress response, where it helps remove DNA frag-
ments released from stalled replication forks [38]. In 
the absence of SAMHD1, constitutive activation of the 
cGAS/STING pathway ensues, providing an explanation 
as to why mutations in this locus is linked to the devel-
opment of various cancers and the autoimmune disease 
Aicardi-Goutières Syndrome. In addition, SAMHD1 
was shown to inhibit NF-κB responses by interact-
ing with the p50 and p52 subunits, and to block IRF7-
mediated ISRE transactivation [39]. Given its role in 
counteracting intrinsic immune pathways, it is perhaps 
not surprising that targeting SAMHD1 for proteasomal 
degradation results in the activation of these pathways 
ordinarily kept in check. An interesting finding of this 
study is that Vpx has the ability to trigger ISRE activa-
tion during HIV-1  infection to higher levels even in the 
absence of SAMHD1, indicating the involvement of a 
separate mechanism. The exact determinants of this acti-
vation remain to be elucidated, but may involve increased 
transcriptional activity from IFN-β and ISRE-responsive 
promoters.
In reporter assays using 293T cells, we observed only a 
mild increase in transcriptional activity from the IFN-β 
and ISRE-driven expression. Whether this relatively 
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modest stimulation is sufficient to explain the elevated 
responses observed during HIV-1  infection remains 
under discussion. As mentioned above, loss of SAMHD1 
can trigger the activation of antiviral signaling pathways, 
suggesting Vpx may have both SAMHD1-dependent 
and independent functions with regard to stimulation 
of innate immune responses during infection. Interest-
ingly, the presence of Vpx during infection of THP-1 cells 
with Sendai Virus did not cause a significant difference 
in ISG stimulation, indicating Vpx may have a specific 
role of stimulating responses during HIV-2 or SIV infec-
tions, possibly through its interaction with viral proteins 
or with host proteins activated during infection. Alterna-
tively, the strong IFN response caused by SeV infection 
could potentially mask any modest effects that Vpx may 
exert during infection.
The vpx gene is homologous to the vpr gene present 
in all primate lentiviruses. As HIV-1 does not contain 
Vpx or any other gene that counteracts the function of 
SAMHD1, the significance of this restriction factor for 
HIV-1 replication in  vivo has remained uncertain. In a 
pig-tailed macaque model of SIVsmm infection, dele-
tion of vpx resulted in a significant defect in replication 
[40]. Moreover, in simultaneous infection of WT and 
Δvpx viruses, the mutant virus is readily outcompeted 
by the WT virus, underlining the importance of this 
viral gene in  vivo [40]. SIVmne infection of pig-tailed 
macaques with Δvpx virus resulted in significantly lower 
levels of plasma viremia [41]. Therefore, Vpx seems to 
be necessary for viral replication in  vivo, and enhanced 
ISG responses could pose a conflict for the virus, which 
largely goes “under the radar” compared to other viruses. 
From an evolutionary standpoint it may seem counterin-
tuitive for a virus to keep a gene that causes the activa-
tion of host antiviral pathways. We reason that it is not 
a primary function of Vpx, but rather a side-effect that 
needs to be tolerated for efficient infection. Enhanced 
activation of ISG responses might be a small compromise 
in exchange for the significant improvement of infection 
levels for SIVs and HIV-2 in vivo. Although the stimula-
tion by Vpx occurs in a SAMHD1-independent manner, 
this type of compromise could be at play that balances 
an activity of Vpx that is beneficial to the virus, while 
enhancing innate immune responses.
Conclusions
Retroviral Vpx gene from HIV-2 and some SIV strains 
carry out various functions during infection, includ-
ing counteraction of host restriction and resistance 
factors. Vpx enhances the ISG signaling observed dur-
ing HIV-1  infection in monocytic cell lines and pri-
mary MDMs. At equal infection levels, Vpx-containing 
viruses cause significantly higher ISG induction than 
their Vpx-lacking counterparts, even in the absence of 
SAMHD1. Overcoming SAMHD1 restriction in MDMs 
to achieve equal infection levels uncover an innate 
immune signaling enhancer activity of Vpx, which likely 
depends on the targeting of a host protein for degrada-
tion. Overall these data reveal a novel activity of Vpx and 
has implications for studies investigating innate immune 
responses against retroviral infections.
Methods
Cell culture
293T and HEK-Blue IFN-α/β cells (Invivogen) were 
maintained in DMEM containing 10% FBS and 100 µg/ml 
Pen/Strep (ThermoFisher). THP-1 Lucia ISG cells were 
from Invivogen, THP-1 SAMHD1 KO and WT control 
cells were kindly provided by Torsten Schaller. All THP-1 
based cells were maintained in RPMI (Gibco) with 10% 
FBS, 100 µg/ml Pen/Strep, 100 µg/ml Normocin. For dif-
ferentiation, THP-1 cells were treated with PMA (25 ng/
ml) for 24 h, followed by fresh media addition. PBMCs 
were isolated from buffy coats of anonymous blood 
donors from the Red Cross using standard Ficoll sepa-
ration. Monocytes were selected by adhering PBMCs in 
RPMI with 5% human serum, 1 mM HEPES and 24 µg/
ml gentamicin for several hours, followed by washing to 
remove unbound cells. Monocyte-derived macrophages 
were differentiated from monocytes by adding GM-CSF 
(50 ng/ml) for 7–14 days with freshly added GM-CSF 
every other day.
Virus production and infection
Virus stocks were produced by standard transfection 
of 293T cells with polyethylenimine (PEI), followed by 
media change, filtering, and ultracentrifugation with 
a sucrose cushion to concentrate virus, which was ali-
quoted and frozen at − 80 °C. Virus-containing superna-
tants were treated with benzonase prior to addition onto 
cells. Infections were done by spinoculation at 1200×g 
for 1 h at 25  °C. Infectious units were determined on 
TZM-Bl cells followed by X-gal staining, or in case of 
GFP viruses on 293T cells by flow cytometry. p24 levels 
were quantified by ELISA; RT activity was determined by 
a Taqman qPCR-based PERT assay.
HIV-1GFP or HIV-1Luc was produced transfection of 
the pNL4.3 e- r- based plasmids that carry either GFP or 
firefly Luciferase in place of the env gene, together with a 
plasmid encoding myc-tagged VSV-G env (pVSV-G). For 
virus packaging of Vpx, a plasmid encoding myc-tagged 
 SIVmac239 vpx gene was transfected simultaneously. To 
allow efficient Vpx incorporation, pNL4.3 e- r-plasmids 
with a modified p6 region from SIV (amino acids 17–26) 
was used, as previously described [26]. HIV-2 was pro-
duced by transfection of the single-round vector pHIV2.
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GFP e- r- [42] or pHIV2.GFP e- r- x- (Δvpx) with VSV-G 
plasmid. VLPs were produced by co-transfection of plas-
mids carrying HIV-1 gag pol with the same p6 aa 17–26 
modification (pMDL gag/pol SIVp6 17–26), rev (pRSV-
rev), VSV-G with or without Vpx. As a general rule, 
infection of difficult-to-infect cells (MDM, differentiated 
THP-1) was scored at 3 dpi, whereas infection of cells 
in which infection proceeds faster (e.g. undifferentiated 
THP-1) was scored at 2 dpi. ISG mRNA quantification 
and WB for SAMHD1 degradation were performed at 2 
dpi.
PERT assay and RT‑qPCR
RT activity of viral stocks was measured by PERT assay, 
as previously described [43]. Briefly viral supernatants 
were mixed with an equal volume of lysis buffer (0.25 % 
Triton X-100, 50 mM KCL, 100 mM TrisHCL pH 7.4, 
40 % glycerol, 0.4U/µl RNase inhibitor), incubated for 15 
mins at room temperature and diluted 1:10 with water. 
qPCR was performed on diluted virus lysate or RT stand-
ards (Cavidi) in a 20 µl reaction containing 500 nM each 
of forward and reverse primers, 250 nM of the Taqman 
probe, 40 ng MS2 RNA, and 1X SensiFAST Probe No-
ROX Master Mix (BioCat). Reactions were run on a Bio-
Rad CFX96 cycler.
For mRNA expression analysis, total RNA was col-
lected isolated using RNeasy Mini Kit (Qiagen), cDNA 
was synthesized using Superscript III cDNA synthesis 
kit (Invitrogen), treated with Turbo DNase and inactiva-
tion reagent (Ambion), and qPCR was performed with 
the SensiFAST Probe No-ROX or SYBR Master Mix 
Table 1 List of primers and probes used in this study
Primer/Probe Sequence (5′−3′) References
PERT-F TCC TGC TCA ACT TCC TGT CGAG Horie et al. [43]
PERT-R CAC AGG TCA AAC CTC CTA GGA ATG 
PERT-Probe TCT TTA GCG AGA CGC TAC CAT GGC TA
IFNB1-F TTG ACA TCC CTG AGG AGA TTA AGC Hillyer et al. [44]
IFNB1-R TTA GCC AGG AGG TTC TCA ACA ATA G
IFNB1-Probe CCA GAA GGA GGA CGC CGC ATT GAC C
HRPT1-F TCT TTG CTG ACC TGC TGG ATT This paper
HPRT1-R TTA TGT CCC CTG TTG ACT GGT 
HPRT1-probe AGT GAT AGA TCC ATT CCT ATG ACT GT
IFIT1-F AAC AGG TTT TCG CAA TCA GGC 
IFIT1-R GCT CCA GAC TAT CCT TGA CCTG 
IFIT1-probe AGA TTG CCT CCT CCC TGG AA
IFIT2-F AAC AGC TGA GAA TTG CAC TGC 
IFIT2-R GCC AGT AGG TTG CAC ATT GTG 
IFIT2-probe TTC CTT GGA GAG CAG CCT AC
MX1-F ATC CTG GGA TTT TGG GGC TT Sumner et al. [28]
MX1-R CCG CTT GTC GCT GGT GTC G
CXCL10-F TGG CAT TCA AGG AGT ACC TC
CXCL10-R TTG TAG CAA TGA TCT CAA CACG 
IFI44L-F GTA TAG CAT ATG TGG CCT TGC TTA CT Zahoor et al. [45]
IFI44L-R ATG ACC CGG CTT TGA GAA GTC 
IFI27-F GGC AGC CTT GTG GCT ACT CT
IFI27-R ATG GAG CCC AGG ATG AAC TTG 
ISG15-F ACT CAT CTT TGC CAG TAC AGGAG 
ISG15-R CAG CAT CTT CAC CGT CAG GTC 
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(BioCat), based on the Taqman or SYBR qPCRs. A list 
of primer/probe sequences and sources is provided in 
Table 1.
Luciferase assays
IFN-β-Luc and ISRE-Luc plasmids were described before 
[46]. For firefly luciferase, cells were lysed in passive lysis 
buffer and mixed with the assay substrate (Promega). For 
Lucia luciferase assays, supernatants were collected and 
mixed with Quanti-Luc substrate (Invivogen). Lumi-
nescence measurements were done using a LUMIstar 
OMEGA plate reader (BMG).
Flow cytometry
Adherent cells were incubated with Accutase (Stemcell) 
at 37 °C for 20 min, or suspension cells were simply col-
lected, washed once with PBS, stained with a fixable-
viability dye (FVD-660; eBioscience), fixed in IC fixation 
buffer (eBioscience), and diluted in PBS to be analyzed by 
flow cytometry (FACScalibur, BD). Further analyses were 
performed in FlowJo.
Western blot
Cells were washed with PBS and lysed in 100 mM Tris, 
30 mM NaCl, 0.5% NP40. Lysates were supplemented 
with 4x loading buffer (Invitrogen) and ran on denaturing 
SDS-PAGE, transferred to PVDF membrane, incubated 
first with blocking solution (Rockland), then with pri-
mary antibodies (1:1000), washed with PBS-T, incubated 
with IRdye-labeled secondary antibody (Licor), washed, 
and scanned using Odyssey infrared scanner (Licor). The 
primary antibodies used were: mouse anti-SAMHD1 
(Bio-Rad), rabbit anti-pT592-SAMDH1 (Cell Signaling 
Technology), mouse anti-tubulin (Sigma); mouse anti-
GAPDH (Thermo), mouse anti-myc (Sigma).
SEAP assay and ELISA
Supernatants to be assayed were collected from infected 
cells and incubated in 96-well plates (25K/well) with 
freshly split HEK-Blue IFN-α/β cells overnight. The 
next day, supernatants from HEK-Blue cells were mixed 
with Quanti-Blue reagent (Invivogen) and absorbance 
was measured at 650 nm. Type I IFN secretion in cul-
ture supernatants was quantified by the IFN-α “all sub-
type” and IFN-β ELISA kits according to manufacturer’s 
instructions (PBL).
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